MedTrace Logo

Pilot Study of Safety and Tolerability of Nutrifriend Cachexia in COPD Cachexia

NCT02442908 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2020-12-24

No results posted yet for this study

Summary

SF-K002 is a pilot study in patients with moderate to severe COPD suffering from involuntary weight loss. The study is 12 weeks, double-blinded, placebo controlled and the main objective is to study the safety and tolerability of Nutrifriend Cachexia.

Conditions

Interventions

DIETARY_SUPPLEMENT

Nutrifriend Cachexia

2 daily for 12 weeks

DIETARY_SUPPLEMENT

Isocaloric placebo

2 daily for 12 weeks

Sponsors & Collaborators

  • Smartfish AS

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-05-31
Primary Completion
2016-04-30
Completion
2016-06-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02442908 on ClinicalTrials.gov